These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cholecystokinin octapeptide analogues suppress food intake via central CCK-A receptors in mice. Hirosue Y, Inui A, Teranishi A, Miura M, Nakajima M, Okita M, Nakajima Y, Himori N, Baba S, Kasuga M. Am J Physiol; 1993 Sep; 265(3 Pt 2):R481-6. PubMed ID: 8214137 [Abstract] [Full Text] [Related]
11. Effects of cholecystokinin tetrapeptide and sulfated cholecystokinin octapeptide in rat models of anxiety. Rex A, Barth T, Voigt JP, Domeney AM, Fink H. Neurosci Lett; 1994 May 19; 172(1-2):139-42. PubMed ID: 8084519 [Abstract] [Full Text] [Related]
12. Reversed behavioral effect of cholecystokinin after frontal decortication in rats. Itoh S, Katsuura G, Itoh T, Morimoto T. Life Sci; 1994 May 19; 55(11):PL213-6. PubMed ID: 8072383 [Abstract] [Full Text] [Related]
13. Cholecystokinin receptor subtypes and neuromodulation. Altar CA. Prog Neuropsychopharmacol Biol Psychiatry; 1989 May 19; 13(3-4):381-93. PubMed ID: 2748871 [Abstract] [Full Text] [Related]
14. Intraventricular CCK-8 reduces single meal size in the baboon by interaction with type-A CCK receptors. Figlewicz DP, Nadzan AM, Sipols AJ, Green PK, Liddle RA, Porte D, Woods SC. Am J Physiol; 1992 Oct 19; 263(4 Pt 2):R863-7. PubMed ID: 1415799 [Abstract] [Full Text] [Related]
15. A-71623, a selective CCK-A receptor agonist, suppresses food intake in the mouse, dog, and monkey. Asin KE, Bednarz L, Nikkel AL, Gore PA, Nadzan AM. Pharmacol Biochem Behav; 1992 Aug 19; 42(4):699-704. PubMed ID: 1513850 [Abstract] [Full Text] [Related]
16. Brain CCK-B receptors mediate the suppression of dopamine release by cholecystokinin. Altar CA, Boyar WC. Brain Res; 1989 Apr 03; 483(2):321-6. PubMed ID: 2706523 [Abstract] [Full Text] [Related]
17. Differential startle reactivity following central CCK-8S and systemic Boc CCK-4 administration in mice: antecedent stressor history and testing condition. Hebb AL, Zacharko RM, Bowie JP, Drolet G. Behav Neurosci; 2003 Aug 03; 117(4):704-15. PubMed ID: 12931956 [Abstract] [Full Text] [Related]
18. Stimulation of either cholecystokinin receptor subtype reduces while antagonists potentiate or sensitize a morphine-induced excitatory response. Felicio LF, Mazzini BK, Cacheiro RG, Cruz TN, Flório JC, Nasello AG. Peptides; 2001 Aug 03; 22(8):1299-304. PubMed ID: 11457524 [Abstract] [Full Text] [Related]
19. Behavioral effects of cholecystokinin and its related peptides in rats. Itoh S, Katsuura G. Prog Clin Biol Res; 1985 Aug 03; 192():139-45. PubMed ID: 2934743 [Abstract] [Full Text] [Related]
20. Ethological analysis of cholecystokinin (CCKA and CCKB) receptor ligands in the elevated plus-maze test of anxiety in mice. Johnson NJ, Rodgers RJ. Psychopharmacology (Berl); 1996 Apr 03; 124(4):355-64. PubMed ID: 8739551 [Abstract] [Full Text] [Related] Page: [Next] [New Search]